Stock ownership
Denali Therapeutics Inc.
- Ticker
- DNLI
- CUSIP
- 24823R105
- Held by
- 2 funds
- Combined value
- $72,902,323
+% bought more, −% sold down — each fund's last-quarter move (change in share count).
| Fund | Quarter | Last quarter | Value | % of fund |
|---|---|---|---|---|
| Baker Bros. Advisors position history | Q1 2026 | — | $71,648,544 | 0.41% |
| Polen Capital Management position history | Q1 2026 | +143% | $1,253,779 | 0.01% |